GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (XTER:FRE) » Definitions » Cyclically Adjusted Revenue per Share

Fresenius SE KGaA (XTER:FRE) Cyclically Adjusted Revenue per Share : €66.83 (As of Dec. 2023)


View and export this data going back to 1992. Start your Free Trial

What is Fresenius SE KGaA Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Fresenius SE KGaA's adjusted revenue per share for the three months ended in Dec. 2023 was €10.081. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €66.83 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Fresenius SE KGaA's average Cyclically Adjusted Revenue Growth Rate was 5.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 8.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 8.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Fresenius SE KGaA was 8.60% per year. The lowest was 7.90% per year. And the median was 8.60% per year.

As of today (2024-05-21), Fresenius SE KGaA's current stock price is €27.75. Fresenius SE KGaA's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was €66.83. Fresenius SE KGaA's Cyclically Adjusted PS Ratio of today is 0.42.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Fresenius SE KGaA was 1.59. The lowest was 0.32. And the median was 0.72.


Fresenius SE KGaA Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Fresenius SE KGaA's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA Cyclically Adjusted Revenue per Share Chart

Fresenius SE KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.54 52.21 57.60 63.41 66.83

Fresenius SE KGaA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.41 65.72 66.89 67.28 66.83

Competitive Comparison of Fresenius SE KGaA's Cyclically Adjusted Revenue per Share

For the Medical Care Facilities subindustry, Fresenius SE KGaA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius SE KGaA's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's Cyclically Adjusted PS Ratio falls into.



Fresenius SE KGaA Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Fresenius SE KGaA's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=10.081/123.7729*123.7729
=10.081

Current CPI (Dec. 2023) = 123.7729.

Fresenius SE KGaA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 9.556 99.543 11.882
201406 10.020 99.543 12.459
201409 11.026 99.823 13.671
201412 11.936 99.543 14.841
201503 11.831 99.717 14.685
201506 12.587 100.417 15.515
201509 12.613 100.417 15.547
201512 13.198 99.717 16.382
201603 12.730 100.017 15.754
201606 13.124 100.717 16.128
201609 13.402 101.017 16.421
201612 14.180 101.217 17.340
201703 14.962 101.417 18.260
201706 15.329 102.117 18.580
201709 14.849 102.717 17.893
201712 15.567 102.617 18.776
201803 14.542 102.917 17.489
201806 15.014 104.017 17.866
201809 14.637 104.718 17.300
201812 15.825 104.217 18.794
201903 15.216 104.217 18.071
201906 15.782 105.718 18.477
201909 15.704 106.018 18.334
201912 16.663 105.818 19.490
202003 16.359 105.718 19.153
202006 16.031 106.618 18.610
202009 15.968 105.818 18.677
202012 16.656 105.518 19.538
202103 16.081 107.518 18.512
202106 16.577 108.486 18.913
202109 16.706 109.435 18.895
202112 17.845 110.384 20.010
202203 17.404 113.968 18.901
202206 17.787 115.760 19.018
202209 9.564 118.818 9.963
202212 10.067 119.345 10.441
202303 18.154 122.402 18.357
202306 19.423 123.140 19.523
202309 9.786 124.195 9.753
202312 10.081 123.773 10.081

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Fresenius SE KGaA  (XTER:FRE) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Fresenius SE KGaA's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=27.75/66.83
=0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Fresenius SE KGaA was 1.59. The lowest was 0.32. And the median was 0.72.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Fresenius SE KGaA Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius SE KGaA (XTER:FRE) Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.
Executives
Dr. Michael Moser Board of Directors
Sara Hennicken Board of Directors
Michael Sen Board of Directors
Dr. Francesco De Meo Board of Directors
Stephan Sturm Board of Directors
Wolfgang Kirsch Supervisory Board
Mats Henriksson Board of Directors
Dr. Gerd Krick Supervisory Board

Fresenius SE KGaA (XTER:FRE) Headlines

No Headlines